Researcher.Life Logo

All Life : Impact Factor & More

eISSN: 2689-5307pISSN: 2689-5293
JournalOpen Access

Key Metrics

CiteScore
0.8
H-Index
44
Impact Factor
< 5
SJR
Q3Neuroscience (miscellaneous)
SNIP
0.27
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on All Life

All Life Journal Specifications

Overview
Publisher TAYLOR & FRANCIS LTD
Language English
Frequency Continuous publication
Article Processing ChargesGBP 1460
Publication Time12
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2020
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 12
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in All Life ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in All Life

GLI2 and NANOG in epithelial ovarian cancer: molecular pathways driving carboplatin resistance
  • 31 Dec 2026
  • All Life
Temporal dynamics of airborne fungal succession and detection of azole-resistant Aspergillus fumigatus in a poultry farm over a nine-week production cycle
  • 31 Dec 2026
  • All Life
Phenotype transformation toward hypersensitivity to soreness in post-exercise muscle
  • 31 Dec 2026
  • All Life
Analysis of potential biomarkers and risk factors for rheumatoid arthritis with sarcopenia-osteomalacia based on 1H NMR technique: a case-control study
  • 31 Dec 2026
  • All Life
Uncovering the hidden leaf mycobiota of native juniper (Juniperus seravschanica) in Oman's arid highlands
  • 31 Dec 2026
  • All Life
Costunolide suppresses breast cancer progression in SK-BR-3 cells through CDK2/Cyclin E-mediated G1/S arrest, mitochondrial apoptosis, and PI3K/Akt-dependent inhibition of epithelial-mesenchymal transition
  • 31 Dec 2026
  • All Life
GLI2 and NANOG in epithelial ovarian cancer: molecular pathways driving carboplatin resistance
  • 31 Dec 2026
  • All Life
Temporal dynamics of airborne fungal succession and detection of azole-resistant Aspergillus fumigatus in a poultry farm over a nine-week production cycle
  • 31 Dec 2026
  • All Life
Phenotype transformation toward hypersensitivity to soreness in post-exercise muscle
  • 31 Dec 2026
  • All Life
Analysis of potential biomarkers and risk factors for rheumatoid arthritis with sarcopenia-osteomalacia based on 1H NMR technique: a case-control study
  • 31 Dec 2026
  • All Life
Uncovering the hidden leaf mycobiota of native juniper (Juniperus seravschanica) in Oman's arid highlands
  • 31 Dec 2026
  • All Life
Costunolide suppresses breast cancer progression in SK-BR-3 cells through CDK2/Cyclin E-mediated G1/S arrest, mitochondrial apoptosis, and PI3K/Akt-dependent inhibition of epithelial-mesenchymal transition
  • 31 Dec 2026
  • All Life

FAQs on All Life